INKON LIFE TECHNOLOGY CO., LTD. Financials INKON Life Technology Co., Ltd.
Equities
300143
CNE100000XF6
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.94 CNY | -0.13% |
|
+7.73% | -25.31% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,131 | 12,715 | 9,032 | 6,800 | 5,079 | - | - |
| Enterprise Value (EV) 1 | 5,131 | 12,715 | 9,032 | 6,800 | 5,079 | 5,079 | 5,079 |
| P/E ratio | -7.29 x | 90 x | -24.8 x | 66.4 x | 37.8 x | 31.1 x | 24.8 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | 19.2 x | 8.29 x | 4.62 x | 2.86 x | 2.48 x | 2.18 x |
| EV / Revenue | - | 19.2 x | 8.29 x | 4.62 x | 2.86 x | 2.48 x | 2.18 x |
| EV / EBITDA | - | 111 x | -32.7 x | 32.5 x | 19.4 x | 16.1 x | 13.2 x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Price to Book | - | 5.75 x | 5.11 x | 4.94 x | 3.62 x | 2.99 x | 2.66 x |
| Nbr of stocks (in thousands) | 545,854 | 642,167 | 639,659 | 639,658 | 639,658 | - | - |
| Reference price 2 | 9.400 | 19.80 | 14.12 | 10.63 | 7.940 | 7.940 | 7.940 |
| Announcement Date | 4/24/20 | 4/27/21 | 4/28/22 | 4/21/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | - | 661.1 | 1,090 | 1,471 | 1,776 | 2,051 | 2,332 |
| EBITDA 1 | - | 114.1 | -276.4 | 209.5 | 261.9 | 316.2 | 386.1 |
| EBIT 1 | - | 38.14 | -325.3 | 142 | 187.9 | 232.3 | 287.8 |
| Operating Margin | - | 5.77% | -29.84% | 9.66% | 10.58% | 11.33% | 12.35% |
| Earnings before Tax (EBT) 1 | - | 171 | -324.6 | 131.5 | 177.4 | 221.5 | 276.3 |
| Net income 1 | -703.4 | 128.1 | -364.1 | 100.4 | 133.2 | 166.6 | 207.4 |
| Net margin | - | 19.38% | -33.41% | 6.83% | 7.5% | 8.12% | 8.9% |
| EPS 2 | -1.290 | 0.2200 | -0.5700 | 0.1600 | 0.2100 | 0.2550 | 0.3200 |
| Free Cash Flow | - | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 4/24/20 | 4/27/21 | 4/28/22 | 4/21/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 7.51% | -15.3% | 7.54% | 9.28% | 9.56% | 10.7% |
| ROA (Net income/ Total Assets) | - | - | - | - | 5% | 5.9% | 6.8% |
| Assets 1 | - | - | - | - | 2,663 | 2,824 | 3,050 |
| Book Value Per Share 2 | - | 3.440 | 2.760 | 2.150 | 2.200 | 2.660 | 2.990 |
| Cash Flow per Share 2 | - | 0.1400 | 0.2000 | 0.3000 | 0.4900 | 0.4100 | 0.4800 |
| Capex 1 | - | 50.9 | 56.2 | 158 | 112 | 127 | 140 |
| Capex / Sales | - | 7.7% | 5.16% | 10.75% | 6.33% | 6.18% | 5.99% |
| Announcement Date | 4/24/20 | 4/27/21 | 4/28/22 | 4/21/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.94
CNY
Average target price
10.12
CNY
Spread / Average Target
+27.46%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -25.31% | 701M | |
| -20.16% | 16.21B | |
| +4.50% | 12.44B | |
| +3.98% | 11.58B | |
| +4.63% | 10.79B | |
| -0.21% | 7.68B | |
| +18.43% | 7.06B | |
| +4.49% | 6.67B | |
| +50.89% | 4.66B | |
| -5.12% | 4.25B |
- Stock Market
- Equities
- 300143 Stock
- Financials INKON Life Technology Co., Ltd.
